GLP-1 Medications in 2026: The Full List, the Real Access Routes, and How Not to Get Burned

GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after you eat. It prompts the pancreas to release insulin when blood sugar rises, slows how fast the stomach empties, and sends a fullness signal to the brain. The natural version breaks down within minutes. GLP-1 medications are engineered versions of that same signal built to last for days, which is why most of them are a once-weekly injection instead of something you take with every meal.

The label gets stretched in marketing, so it is worth drawing the line clearly. Semaglutide, liraglutide, dulaglutide and exenatide are true GLP-1 receptor agonists. Tirzepatide is a dual agonist, meaning it acts on the GLP-1 receptor and the GIP receptor, and it is grouped with the class in practice even though it is technically a step beyond it. A capsule sold as GLP-1 support, a herbal blend promising the same effect, and an unlabeled vial sold for research are none of these things. For a full side-by-side of the molecules, what each brand is approved to treat, and how they differ in dosing and delivery, this roundup of GLP-1 medications is a useful map to keep open, and anything that will drive a real decision is worth checking against the FDA label itself.

Everything below assumes the goal is a legitimate prescription. That framing matters here, because most of the money lost in this category is not lost to an expensive brand. It is lost to a storefront that took a card and never involved a clinician.

The single most useful thing to understand about this class is that the same molecule is often sold under two names carrying two different labels. Semaglutide is Ozempic when the approved use is type 2 diabetes and Wegovy when it is chronic weight management. Tirzepatide is Mounjaro for diabetes and Zepbound for weight management. Same active drug, different box, different approved use.

This matters because coverage follows the label, not the molecule. A plan that will not touch a weight management drug may cover the identical molecule under its diabetes label if you carry that diagnosis. It matters clinically too, since dosing schedules and maximum strengths are not always identical across the two labels. The name on the box is not cosmetic.

Oral options exist as well. Oral semaglutide is a daily tablet with specific instructions about taking it on an empty stomach with a small sip of water and waiting before eating or taking anything else. Small-molecule GLP-1 pills have been the most closely watched part of the pipeline and the regulatory picture has moved quickly, so treat any pill claim you read, including on this site, as something to confirm against current FDA labeling before you build a plan around it.

Averages are the honest way to talk about this. In the STEP 1 trial, adults taking semaglutide 2.4 mg weekly lost roughly 15 percent of body weight over 68 weeks, against roughly 2 percent in the placebo group, with both groups receiving lifestyle counseling. In SURMOUNT-1, tirzepatide produced mean reductions in the region of 15 to 21 percent over 72 weeks depending on the dose. In the SCALE program, daily liraglutide 3.0 mg came in near 8 percent at 56 weeks.

Two caveats do more work than the numbers themselves. First, these are means, and the spread around them is wide. Some people in the same treatment arm lost very little and some lost far more than the headline figure. Second, every one of those trials paired the medication with structured diet and activity support, so the results are not the drug operating on its own.

There is also evidence beyond the scale. The SELECT trial found that semaglutide 2.4 mg reduced major adverse cardiovascular events by roughly 20 percent in adults with overweight or obesity and established cardiovascular disease who did not have diabetes. That is worth raising with a prescriber, because findings like it can change which medication is right for you rather than just how much weight it moves.

Route one is insurance with a covered indication. If your plan covers the drug for your diagnosis and you clear prior authorization, this is usually the lowest out-of-pocket cost by a wide margin. It is also the slowest, and denials are common, so ask your prescriber's office what documentation they normally submit before the first attempt rather than after a rejection.

Route two is paying cash through a manufacturer's own self-pay channel. The supply chain is unambiguous, which is the main reason to like it. The trade-off is that some self-pay products arrive as vials rather than pens, so you are measuring a dose yourself and the instructions matter more than they would with a dial.

Route three is telehealth. A good program folds the consult, the prescription and pharmacy coordination into one place, which is genuinely convenient. The price only makes sense once you know what the maintenance dose costs, whether follow-up messages are billed separately, and which pharmacy is dispensing. Our provider reviews exist for that comparison, and the telehealth weight loss overview explains how these programs are usually structured.

Route four is compounded medication, and it carries a higher verification bar. A compounded product is not an FDA-approved finished drug, and the legal basis for compounding a copy of a commercially available drug is tied to shortage status, which has changed more than once. That does not make every compounded prescription illegitimate, but it does mean you want the pharmacy name, the concentration, the legal basis and a named clinician before you pay rather than after.

The advertised number is almost always the friendliest version of the offer: starter dose, first month, before fees. Because this class is titrated upward over weeks, the price that matters is the one attached to the dose you expect to settle on, not the one on the checkout screen in week one.

The items that move the total are predictable once you know to ask. Dose escalation pricing, any membership or consult fee sitting on top of the medication, lab work, needles and sharps disposal, shipping including cold chain, whether refill consults are billed, and what happens if you cancel mid-cycle. Add six months of all of it together and competing offers reorder themselves surprisingly often. Our cost breakdowns are built the same way, by total rather than by teaser.

The checks below are the ones we would not skip. None of them require medical knowledge, and all of them can be confirmed in a few minutes before you hand over a card.

The pattern worth internalizing is simple: legitimate operations tell you things before payment, and storefronts tell you after. A real program will name the prescribing clinician, name the dispensing pharmacy, and state the maintenance price without a card on file. If any of those only appear once you have paid, that is your answer. If you want a structured version of this test, run the offer through our scam checker before you commit.

The common effects are gastrointestinal: nausea, vomiting, diarrhea, constipation. They tend to be dose related, tend to be worst in the days after an increase, and tend to settle. That pattern is the reason titration is deliberately slow, and it is why pushing the dose up faster than the schedule is a poor trade.

The less common but more serious concerns include pancreatitis and gallbladder problems. This class also carries a boxed warning about thyroid C-cell tumors based on rodent studies, and it is not used in people with a personal or family history of medullary thyroid carcinoma or MEN 2. These medications are not for use in pregnancy, and because they slow gastric emptying they can affect how other oral medicines are absorbed, which is a specific question worth asking if you take oral contraception or a narrow-margin oral drug.

Two practical points get missed. Some of the weight lost is lean mass, so protein intake and resistance training belong in the plan rather than beside it. And stopping usually means weight returns, so ask what month twelve looks like before you commit to month one. Our side effects guide covers the management side in more detail. None of this replaces a conversation with a prescribing clinician who has your history in front of them.

Two things vary by state. The first is who may prescribe to you, because the clinician has to be licensed in the state you are physically in at the time of the visit, and telehealth rules differ. The second is dispensing, because the pharmacy needs a license to ship into your state. That is why an otherwise identical program can be available in one state and unavailable one border over.

Cash price varies too, less because of geography itself and more because of which pharmacies operate near you and which discount programs they accept. If a program cannot tell you whether it can ship to your address before you pay, treat that as information about the program rather than an inconvenience.

GLP-1 medications are a real and well studied class, and there is now more than one honest way to get one. The right route is the one that matches your diagnosis and your coverage, not the one with the loudest advertisement.

Whatever you choose, the same three things have to be true: a licensed clinician who reviewed your history, a named pharmacy you can look up, and a price you understand at the dose you expect to reach. If all three hold, you are in a reasonable position to talk with a prescribing clinician about which molecule fits. If any one of them is missing, that is not a bargain, it is a risk.